CAH vs. MCK, COR, HSIC, PDCO, OMI, HLF, PETQ, NUS, COSM, and MEDS
Should you be buying Cardinal Health stock or one of its competitors? The main competitors of Cardinal Health include McKesson (MCK), Cencora (COR), Henry Schein (HSIC), Patterson Companies (PDCO), Owens & Minor (OMI), Herbalife (HLF), PetIQ (PETQ), Nu Skin Enterprises (NUS), Cosmos Health (COSM), and TRxADE HEALTH (MEDS).
Cardinal Health (NYSE:CAH) and McKesson (NYSE:MCK) are both large-cap medical companies, but which is the superior business? We will compare the two companies based on the strength of their dividends, risk, analyst recommendations, profitability, earnings, community ranking, media sentiment, institutional ownership and valuation.
Cardinal Health has a beta of 0.61, suggesting that its share price is 39% less volatile than the S&P 500. Comparatively, McKesson has a beta of 0.45, suggesting that its share price is 55% less volatile than the S&P 500.
Cardinal Health pays an annual dividend of $2.02 per share and has a dividend yield of 2.1%. McKesson pays an annual dividend of $2.48 per share and has a dividend yield of 0.4%. Cardinal Health pays out 89.8% of its earnings in the form of a dividend, suggesting it may not have sufficient earnings to cover its dividend payment in the future. McKesson pays out 11.1% of its earnings in the form of a dividend.
87.2% of Cardinal Health shares are held by institutional investors. Comparatively, 85.1% of McKesson shares are held by institutional investors. 0.2% of Cardinal Health shares are held by company insiders. Comparatively, 0.1% of McKesson shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term.
In the previous week, Cardinal Health had 2 more articles in the media than McKesson. MarketBeat recorded 17 mentions for Cardinal Health and 15 mentions for McKesson. Cardinal Health's average media sentiment score of 0.64 beat McKesson's score of 0.62 indicating that Cardinal Health is being referred to more favorably in the media.
McKesson received 52 more outperform votes than Cardinal Health when rated by MarketBeat users. Likewise, 74.34% of users gave McKesson an outperform vote while only 71.68% of users gave Cardinal Health an outperform vote.
McKesson has a net margin of 0.97% compared to Cardinal Health's net margin of 0.25%. Cardinal Health's return on equity of -54.74% beat McKesson's return on equity.
Cardinal Health currently has a consensus price target of $109.67, indicating a potential upside of 11.48%. McKesson has a consensus price target of $599.33, indicating a potential downside of 0.14%. Given Cardinal Health's higher possible upside, analysts clearly believe Cardinal Health is more favorable than McKesson.
McKesson has higher revenue and earnings than Cardinal Health. McKesson is trading at a lower price-to-earnings ratio than Cardinal Health, indicating that it is currently the more affordable of the two stocks.
Summary
McKesson beats Cardinal Health on 11 of the 20 factors compared between the two stocks.
Get Cardinal Health News Delivered to You Automatically
Sign up to receive the latest news and ratings for CAH and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding CAH and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Cardinal Health Competitors List
Related Companies and Tools
Free CAH Stock Alerts